Atlas Trials

A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness

Clinical trial NCT01485770 · COMPLETED

Trial details

NCT number
NCT01485770
Sponsor
Jazz Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Narcolepsy
Start date
2011-12-01
Primary completion
2012-05-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.